Anavex Life Sciences
AVXL
#7563
Rank
A$0.59 B
Marketcap
A$6.62
Share price
-1.12%
Change (1 day)
-43.78%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$17.27 Million

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are A$17.27 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30A$22.12 M13.49%
2023-09-30A$19.49 M22.79%
2022-09-30A$15.87 M6.34%
2021-09-30A$14.93 M46.49%
2020-09-30A$10.19 M36.6%
2019-09-30A$7.46 M38.78%
2018-09-30A$5.37 M17.7%
2017-09-30A$4.56 M9.37%
2016-09-30A$4.17 M10.05%
2015-09-30A$3.79 M-53.69%
2014-09-30A$8.19 M167.4%
2013-09-30A$3.06 M9.89%
2012-09-30A$2.78 M101.96%
2011-09-30A$1.38 M-59.52%
2010-09-30A$3.41 M-30.56%
2009-09-30A$4.91 M69.26%
2008-09-30A$2.9 M461.25%
2007-09-30A$0.51 M1277.55%
2006-09-30A$0.03 M5.61%
2005-09-30A$0.03 M917.27%
2004-09-30A$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.79 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$1.25 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$0.28 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$15.22 M-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA